Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine + Tramadol for Chronic Cancer Pain
NCT05311774Completed
- Sponsor
- Assiut University
- Start
- Apr 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in cancer pain comparing tramadol and duloxetine with tramadol and placebo (2 arms). Primary endpoint: Concentration of tramadol consumption at 1 month. Started Apr 2022; status: completed.
02
Drugs
duloxetine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT05311774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05311774.